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ABSTRACT
West Nile virus (WNV) is an emerging zoonotic mosquito-borne flavivirus responsible for outbreaks of febrile illness andme-
ningoencephalitis. The replication ofWNV takes place on virus-modifiedmembranes from the endoplasmic reticulum of the
host cell, and virions acquire their envelope by budding into this organelle. Consistent with this view, the cellular biology of this
pathogen is intimately linked to modifications of the intracellular membranes, and the requirement for specific lipids, such as
cholesterol and fatty acids, has been documented. In this study, we evaluated the impact ofWNV infection on two important
components of cellular membranes, glycerophospholipids and sphingolipids, by mass spectrometry of infected cells. A signifi-
cant increase in the content of several glycerophospholipids (phosphatidylcholine, plasmalogens, and lysophospholipids) and
sphingolipids (ceramide, dihydroceramide, and sphingomyelin) was noticed inWNV-infected cells, suggesting that these lipids
have functional roles duringWNV infection. Furthermore, the analysis of the lipid envelope ofWNV virions and recombinant
virus-like particles revealed that their envelopes had a unique composition. The envelopes were enriched in sphingolipids (sph-
ingomyelin) and showed reduced levels of phosphatidylcholine, similar to sphingolipid-enriched lipid microdomains. Inhibi-
tion of neutral sphingomyelinase (which catalyzes the hydrolysis of sphingomyelin into ceramide) by either pharmacological
approaches or small interfering RNA-mediated silencing reduced the release of flavivirus virions as well as virus-like particles,
suggesting a role of sphingomyelin-to-ceramide conversion in flavivirus budding and confirming the importance of sphingolip-
ids in the biogenesis ofWNV.
IMPORTANCE
West Nile virus (WNV) is a neurotropic flavivirus spread by mosquitoes that can infect multiple vertebrate hosts, including hu-
mans. There is no specific vaccine or therapy against this pathogen licensed for human use. Since the multiplication of this virus
is associated with rearrangements of host cell membranes, we analyzed the effect ofWNV infection on different cellular lipids
that constitute important membrane components. The levels of multiple lipid species were increased in infected cells, pointing
to the induction of major alterations of cellular lipid metabolism byWNV infection. Interestingly, certain sphingolipids, which
were increased in infected cells, were also enriched in the lipid envelope of the virus, thus suggesting a potential role during virus
assembly. We further verified the role of sphingolipids in the production ofWNV bymeans of functional analyses. This study
provides new insight into the formation of flavivirus infectious particles and the involvement of sphingolipids in theWNV life
cycle.
West Nile virus (WNV) is a mosquito-borne flavivirus that isdistributed worldwide and that is responsible for recurrent
outbreaks of febrile illness and encephalitis. The virus is main-
tained in nature in an enzootic infectious cycle between birds and
mosquitoes, which act as its vectors, although it can also infect
multiple vertebrate hosts, including horses and humans (1, 2).
The continuing spread of WNV due to a variety of ecological fac-
tors, combined with the lack of specific therapeutics or vaccines
for human use, makes the identification of the viral and host pro-
cesses that control the biology of this pathogen important to im-
prove the design of specific antiviral strategies (3).
As a flavivirus,WNV is an enveloped plus-strandRNAvirus (1,
2). A feature that it shares with other plus-strand RNA viruses is
replication in the cytoplasm of infected cells in tight association
with intracellular membrane rearrangements (4). In the case of
flaviviruses and, hence, WNV, the membranes associated with
virus replication are from the endoplasmic reticulum (ER) (5).
Even more, flavivirus particles are assembled by invagination and
budding of the ER membrane into the lumen of this organelle, so
the ER also provides themembrane source forWNVenvelopment
(6). Although the lipid composition of the viral envelopes of a few
distinct viruses has been characterized (7–10), to our knowledge,
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themolecular composition of the flavivirus envelope has not been
analyzed. Only certain lipids in the flavivirus envelope (choles-
terol and phosphatidylserine) have been identified, and these have
been identified by functional studies rather than by analytical ap-
proaches (11, 12).
Lipids are the main components of cellular membranes, play-
ing key roles in viral infections by acting as signalingmolecules, as
well as by determining the physical properties of the membranes,
such as fluidity, thickness, or shape (13, 14). In fact, the strong
manipulation of cellular lipid metabolism by different viruses has
recently been documented (15–17). Accordingly, enrichment in
specific lipids contributes to the generation of amembrane curva-
ture adequate for the correct assembly of the replication complex
or virus budding, and the cone-shaped or inverted cone-shaped
lipids, which can govern membrane bending, budding processes,
or fusion events, are of particular interest (18–20). Although dif-
ferences in the lipid requirements between viruses of the same
family have been noted (21), the dependence on certain lipids,
such as fatty acids (15, 22, 23) or phosphatidylinositol 4-phos-
phate (PI4P) (21, 24), can be shared by unrelated enveloped and
nonenveloped viruses. These observations suggest that each virus
creates its own characteristic cellular microenvironment for rep-
lication by developing specialized virus-induced organelle-like
structures within infected cells (4, 24, 25). Regarding flaviviruses,
major rearrangements of cellular lipid metabolism have been ob-
served in dengue virus (DENV)-infected cells (26, 27), and several
studies have highlighted the importance of both fatty acids and
cholesterol forWNV andDENV infection (22, 28–31), as well as a
lack of a requirement for PI4P (21, 29).
In this study, we have analyzed the effect of WNV infection on
the cellular content of 11 lipid classes. Our results revealed an
increase in the cellular content of multiple lipid species upon
WNV infection, which is consistent with major lipid metabolic
changes in WNV-infected cells. The proportions of these metab-
olites in the envelope ofWNVvirions and virus-like particles were
also determined, unveiling a unique composition of the viral en-
velope and pointing to specific roles of some of these lipids for
virus assembly. Supporting this view, a direct link between specific
lipids (sphingolipids) and WNV biogenesis was found by means
of functional analyses.
MATERIALS AND METHODS
Cells, viruses, infections, and virus titrations. All infectious virus ma-
nipulations were performed in our biosafety level 3 (BSL-3) facilities. The
origins ofWNV strainNY99, Usutu virus (USUV) strain SAAR-1776, and
Sindbis virus (SINV) have been previously described (32). Vero andHeLa
cells were grown at 37°C in a 5%CO2 atmosphere in Dulbecco’s modified
minimum essential medium (DMEM) supplemented with 2 mM glu-
tamine, penicillin-streptomycin, and 5 or 10% fetal bovine serum, respec-
tively. Cells of a HeLa cell line stably transfected with plasmid pcDNA 3.1
() (Invitrogen, Carlsbad, CA) encoding the 25 last amino acids of the
WNV NY99 C protein followed by the sequence of premembrane/mem-
brane (prM) and envelope (E) proteins (HeLa3-WNV cells) were ob-
tained by limiting dilution and grown in complete culture medium sup-
plemented with 500 g/ml G-418 (T. Merino-Ramos, A. B. Blázquez, E.
Escribano-Romero, R. Cañas-Arranz, F. Sobrino, J. C. Saiz, and M. A.
Martín-Acebes, submitted for publication). This line constitutively se-
cretedWNV recombinant subviral particles (RSPs). C6/36mosquito cells
were cultured in M3 medium supplemented with 4 mM glutamine, gen-
tamicin, penicillin-streptomycin, nonessential amino acids, amphoteri-
cin B, and 10% fetal bovine serum at 28°C without CO2. For infections in
liquidmedium, the viral inoculumwas incubatedwith cellmonolayers for
1 h at the temperature appropriate for cell growth, and then the inocu-
lum was removed and fresh medium containing or not containing 1%
fetal bovine serum was added. The viral titer was determined at 24 h
postinfection (p.i.) for WNV and USUV and 8 h p.i. for SINV by
plaque assay on Vero cells (29, 32, 33). Cell-associated virus was ex-
tracted from infected cells by three cycles of freeze and thaw and
titrated as described above. The multiplicity of infection (MOI) used
in each experiment was expressed as the number of PFU/cell and is
indicated in the corresponding figure legend.
Antibodies. Mouse monoclonal antibodies against the WNV enve-
lope (E) protein (Millipore, Temecula, CA), -actin (Sigma, St. Louis,
MO), and GM130 (ECM Biosciences, Versailles, KY) and rabbit sera
againstWNVMprotein (Imgenex, San Diego, CA), calnexin (StressMarq
Biosciences Inc., Victoria, Canada), mannosidase II (Millipore), and sph-
ingomyelin phosphodiesterase 3 (SMPD3), also named neutral sphingo-
myelinase 2 (nSMase2; ECMBiosciences), were used as primary antibod-
ies. Anti-mouse or anti-rabbit IgG coupled to Alexa Fluor 594 or 488
(Invitrogen, Carlsbad, CA) and goat anti-mouse or anti-rabbit IgG cou-
pled to horseradish peroxidase (Pierce Biotechnology, Rockford, IL) were
used as secondary antibodies.
Drug treatments. Brefeldin A (BFA), golgicide A (GCA), GW4869,
and glutathione were from Sigma. Spiroepoxide was from Santa Cruz
Biotechnology (Santa Cruz, CA). BFA, GCA, GW4869, and spiroepoxide
stock solutions were prepared in dimethyl sulfoxide, while glutathione
was directly dissolved in culture medium. Working concentrations of
GW4869 were prepared as described previously (34). Control cells were
treated in a parallel manner with the same amount of drug vehicle. For
estimation of RSP release, the medium from HeLa3-WNV cells was re-
placed by serum-free medium containing the drugs. Cells were incubated
for 4 h, and the amount of RSPs released to the culture medium was
determined by an enzyme-linked immunodot assay using a monoclonal
antibody directed againstWNVE glycoprotein, as described below. In the
case of virus infections, drugs were added after the first hour of infection,
when the viral inoculum was replaced by medium containing 1% fetal
bovine serum. The lack of toxicity of drug concentrations during the
assays was evaluated by determination of the cellular ATP content with a
CellTiter-Glo luminescent cell viability assay (Promega, Madison, WI).
siRNA experiments. HeLa or HeLa3-WNV cells were transfected in
serum-free culture medium with 100 nM endoribonuclease-prepared
small interfering RNAs (esiRNAs) against human SMPD3 (MISSION;
Sigma) or an equivalent amount of MISSION small interfering RNA
(siRNA) universal negative control 1 (MISSION; Sigma) using an siRNA
transfection reagent (MISSION; Sigma), as indicated by the manufac-
turer. To estimate the release of WNV RSPs, the culture medium of
HeLa3-WNV cells was replaced by fresh serum-free medium, and the
amount of RSPs in the culture medium was determined after 4 h of incu-
bation by an enzyme-linked immunodot assay. For viral infections, trans-
fected cells were infected (MOI, 1 PFU/cell) as described above for infec-
tions in liquid medium, and subsequent experiments were performed at
48 h posttransfection. The extent of siRNA silencing was analyzed by
Western blotting (29, 35) using specific antibodies against nSMase2.
Purification of RSPs and virions. HeLa3-WNV cells were incubated
for 48 h in serum-free medium (to avoid the possible interference of
serum with subsequent lipid determinations), and RSPs were purified by
sucrose gradient centrifugation essentially as described previously (36).
Briefly, culture medium from HeLa3-WNV cells was clarified by centrif-
ugation at 15,000  g for 30 min at 4°C and then centrifuged through a
20% sucrose cushion for 3.5 h at 112,000 g at 4°C. The pellet containing
RSPs was resuspended in phosphate-buffered saline (PBS), loaded onto a
12-ml 20 to 60% linear sucrose gradient, and centrifuged at 256,000 g
for 18 h at 4°C. For purification ofWNVparticles,HeLa cells were infected
withWNV(MOI, 5 PFU/cell) in serum-freemediumand incubated for 48
h. The culture medium was cleared of cell debris by centrifugation at
850 g for 15min at 4°C and centrifuged through a 20% sucrose cushion
at 112,000  g for 3.5 h at 4°C. The pellet containing the virions was
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loaded onto a six-step discontinuous 20 to 60% sucrose gradient and
centrifuged at 55,500 g for 18 h at 4°C. Gradients were fractioned from
the top, and the E-protein content of each fraction was determined by
enzyme-linked immunodot assay as described below. Only the fraction
with the highest E-protein content was selected for lipid analyses.
Immunofluorescence and confocalmicroscopy.Cells grown on glass
coverslips were fixed with 4% paraformaldehyde in PBS for 15 min and
processed for immunofluorescence as described previously (29, 35). Cells
were observed using a Leica TCS SPE confocal laser scanning microscope
and an HCX PL Apo 63/1.4 oil immersion objective. Images were ac-
quired using Leica advanced fluorescence software and processed with
Adobe Photoshop CS2 software (Adobe Inc., San Jose, CA). The optical
slice thickness for all confocal images displayed was 1 airy unit.
Transmission electron microscopy. Negative staining of RSPs was
performed in dialyzed samples containing the peak amount of E protein
within the gradient, as described previously (36). For immunolabeling
and negative staining, samples were adsorbed to ionized collodion-car-
bon-coated grids, washed with PBS, and blocked with 10% fetal bovine
serum inPBS for 5min. The gridswere incubatedwith primary antibodies
diluted in 5% fetal bovine serum in PBS for 30min, washed five timeswith
PBS, and incubated with protein A coupled to 5-nm colloidal gold diluted
in 5% fetal bovine serum in PBS for 30min. Samples were then fixed with
1% glutaraldehyde in PBS for 5 min, washed three times with bidistilled
water, and negatively stainedwith 1%uranyl acetate for 2min.HeLa orVero
cells infectedwithWNVwere fixed in 4%paraformaldehyde–2%glutaralde-
hyde in0.1Mphosphatebuffer (pH7.4)at24hp.i. andprocessed for electron
microscopy as described previously (29, 35). Samples were examined using a
JEOL JEM-1010 electron microscope (JEOL, Japan) operated at 80 kV, and
images were acquired using a digital camera (4K64K TemCam-F416; Tietz
Video and Image Processing Systems GmbH, Gauting, Germany).
Enzyme-linked immunodot assay.Cell culture medium (usually 5 to
10 l) was adsorbed to a nitrocellulose membrane by vacuum using a
Bio-Dot apparatus (Bio-Rad, Hercules, CA). For quantification of the
amount of RSPs in the culturemedium and in order to verify that samples
were within the linear range, a standard curve was prepared using different
dilutions. The membrane was blocked with 3% skimmed milk in PBS and
incubated with monoclonal anti-E antibody diluted in 1% skimmedmilk in
PBS. After three washes with PBS, the membranes were incubated with sec-
ondary antibodies coupled to horseradish peroxidase and washed, and pro-
teinswere detectedby chemiluminescenceusing ImageQuant LAS4000mini
equipment (GEHealthcare, Buckinghamshire, United Kingdom).
Quantitative RT-PCR. Viral RNA was extracted with a NucleoSpin
viral RNA isolation kit (Macherey-Nagel, Düren, Germany). The number
of viral RNA copies was determined by quantitative reverse transcription-
PCR (RT-PCR) (37) and is given as the number of genomic equivalents
corresponding to the number of PFU/ml by comparison with the amount
of RNA extracted from previously titrated samples (38).
Lipid analysis. HeLa cells were infected or not infected (mock in-
fected) with WNV (MOI, 50 PFU/cell) in serum-free medium as de-
scribed above for infections in liquid medium, detached from the flasks,
and resuspended in PBS at 24 h p.i. The number of cells in each samplewas
determined, and aliquots containing 2.7 106 cells were subjected to lipid
extractions. The amount of protein in each sample was also determined by
the Bradford assay. Lipids were extracted using a modified Bligh and Dyer
protocol. Cell pellets were resuspended in 100 l of PBS and 750 l of a
methanol-chloroform (1:2, vol/vol) solution containing 0.01%butylated hy-
droxytoluene (BHT) and internal standards (1,2-diheptadecanoyl-sn-
glycero-3-phosphocholine, 1,2-diheptadecanoyl-sn-glycero-3-
phosphoethanolamine, 1,2-diheptadecanoyl-sn-glycero-3-phosphoserine,
1-heptadecanoyl-2-hydroxy-sn-glycero-3-phosphocholine, 1-heptade-
canoyl-2-hydroxy-sn-glycero-3-phosphoethanoamine, and 1-heptade
canoyl-2-hydroxy-sn-glycero-3-phosphoserine, 200 pmol each, fromAvanti
Polar Lipids). Samples were extracted at 48°C overnight and centrifuged
at 13,000  g for 5 min. Then, the supernatant was transferred to a new
vial, evaporated to dryness, and stored at20°C in an argon atmosphere
until the analysis of glycerophospholipids (39). On the other hand, 100l
of PBS and 750 l of a methanol-chloroform (2:1, vol/vol) solution con-
taining 0.01% BHT and internal standards (N-lauroyl-D-erythro-sphin-
gosine, N-lauroyl-D-erythro-sphingosylphosphorylcholine, and D-gluco-
syl--1,1=-N-lauroyl-D-erythro-sphingosine, 200 pmol each, from Avanti
Polar Lipids)were added to the cell pellets. Sampleswere extracted at 48°C
overnight and cooled, 75 l of 1 M KOH in methanol was added, and the
mixture was incubated for 2 h at 37°C. Following addition of 75l of 1M
acetic acid, samples were centrifuged at 13,000  g for 5 min and the
supernatant was transferred to a new vial, evaporated to dryness, and
stored at20°C in an argon atmosphere until the analysis of sphingolip-
ids (40).
Lipids were measured with an Acquity ultraperformance liquid chro-
matography (UPLC) system (Waters, USA) connected to a time-of-flight
(TOF; LCT Premier XE) detector controlled with Waters/Micromass
MassLynx (v.4.1) software. An Acquity UPLC BEH C8 column (particle
size, 1.7 m; 100 mm by 2.1 mm; Waters, Ireland), a flow rate of 0.3
ml/min, and a column temperature of 30°C were used. The mobile phase
was methanol with 1 mM ammonium formate and 0.2% formic acid
(solution A)–water with 2mMammonium formate and 0.2% formic acid
(solution B). Gradient elution started at 80% solution A, was increased to
90% solution A over 3 min, was held for 3 min, was increased to 99%
solution A over 9 min, and was held for 3 min. Initial conditions were
attained in 2min, and the systemwas stabilized for 3min. The acquisition
range of the TOFdetector wasm/z 50 to 1,500, the capillary voltagewas set
to 3.0 kV, the desolvation temperature was 350°C, and the desolvation gas
flow rate was 600 liters/h (41).
Lipid identification was confirmed by the analysis of one sample from
each group with an ultra-high-performance liquid chromatography sys-
tem (Accela) coupled to a Thermo Fisher Scientific LTQ Orbitrap Velos
mass spectrometer (MS) controlled with Thermo Fisher Scientific/Xcali-
bur software using the same column and eluted with the following condi-
tions: gradient elution started at 85% solution A, was increased to 90%
solution A over 9 min, was held for 2 min, was increased to 99% solution
A over 6min, and was held for 2min. Initial conditions were attained in 2
min, and the system was stabilized for 3 min. The acquisition range of the
Orbitrap detector wasm/z 200 to 100, the source voltage was set to 3.5 kV,
the capillary temperature was 350°C, the sheath gas flow rate was 50 li-
ters/h, the auxiliary gas flow rate of 20 liters/h, and the sweep gas flow rate
was 2 liters/h (42).
Individual chromatographic peaks of distinct lipid species were
isolated from full-scanMS spectra when the theoretical exact masses of
the lipid species were selected. The spectra were extracted from a da-
tabase that was previously generated using the spectrum simulation
tool of Micromass MassLynx software on the basis of our previous
results (39). Then, a list of possible candidates fitting the specific exact
mass was generated using formula determination tools (elemental
composition search) of Micromass MassLynx software. The elemental
number was restricted to include C, H, O, N, and P. The formula
constraints were as follows: C, H, and O were 1, P was 0, and N was
1, following the nitrogen rule. The number of double-bond equivalents
(DBEs) was set to be between 0.5 and 15.0. The search was based on
single mass analysis and considered only the m/z value of the monoiso-
topic peak. Positive identification of the lipids was based on accuratemass
measurement with an error 5 ppm, a low i-Fit parameter in the spec-
trum window, and its relative retention time by liquid chromatography
compared to that of the standard (2%) (39). The following lipids from
Avanti Polar Lipids were used: 1,2-dihexadecanoyl-sn-glycero-3-phos-
phocholine, 1,2-dioctadecanoyl-sn-glycero-3-phosphocholine, 1-hexa-
decanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine, 1-hexade-
canoyl-2-(4Z,7Z,10Z,13Z,16Z,19Z-docosahexaenoyl)-sn-glycero-3-
phosphocholine, 1-(9Z-octadecenoyl)-2-hydroxy-sn-glycero-3-
phosphocholine, 1-(1Z-octadecenyl)-2-(9Z-octadecenoyl9-sn-glycero-
3-phosphocholine, 1-octadecanoyl-2-(9Z-octadecenoyl)-sn-
glycero-3-phosphoethanolamine, 1-hexadecanoyl-2-(9Z-octadecenoyl)-
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sn-glycero-3-phospho-L-serine, N-hexadecanoyl-D-erythro-sphingosine,
N-hexadecanoyl-D-erythro-sphingosylphosphorylcholine, and D-gluco-
syl--1,1=-N-hexadecanoyl-D-erythro-sphingosine In addition, identifi-
cations of lipids were made by searching their molecular weights against
entries in the Lipid MAPS database. As mentioned above, this identifica-
tion procedure was confirmed by the analysis of selected samples using
Thermo Fisher ScientificOrbitrap analyzers (resolution, 30,000 full width
at half maximum) (42).
The data presented are the products of 4 to 5 independent lipid extrac-
tions and determinations.
Annotation of lipid species.Glycerophospholipids were annotated as
lipid subclass and total fatty acyl chain length:total number of unsaturated
bonds. Plasmalogens (P) were annotated as described above, except that P
was added. Sphingolipids were annotated as lipid subclass and total fatty
acyl chain length:total number of unsaturated bonds. If the sphingoid
base residue was dihydrosphingosine (dihydro sphingomyelin or dihydro
ceramide), the lipid class contains the prefix dh (dihydro).
Data analysis.Analysis of variance (ANOVA)was performedwith the
SPSS (v.15) statistical package (SPSS Inc., Chicago IL), with Bonferroni’s
correction applied for multiple comparisons. Nonparametric compari-
sons were performed using the statistical package GraphPad Prism
(v.2.01; GraphPad Software Inc., La Jolla, CA). Data are presented as the
mean standard deviation (SD). Differences with P values of0.05 were
considered statistically significant.
RESULTS
Alteration of lipid content inWNV-infected cells.To analyze the
effect ofWNV infection on the lipid content of the host cell, HeLa
cells were infected or not infected at a high multiplicity of infec-
tion (MOI) and processed for lipid analysis at 24 h p.i. At this time
point, infectious virus release into the culturemediumwas already
detected (Fig. 1A). When the cells were observed by transmission
electronmicroscopy, they exhibited intracellular membrane rear-
rangements associated with flavivirus replication and assembly,
such as membrane sacs containing small virus-induced vesicles,
referred to as vesicle packets (VPs) (5, 29, 43), as well as electron-
dense virions (Fig. 1B). As expected, these rearrangements were
not observed in control uninfected cells. Eleven lipid classes
(seven glycerophospholipids [GPLs] and four sphingolipids
[SLs]) were included in the analysis. The GPLs analyzed were
phosphatidylcholine (PC), 1-alkenyl,2-acylglycerolphosphocho-
line (referred to as plasmalogen-PC [p-PC; plasmenylcholine]),
2-acylglycero-3-phosphocholine (lyso-PC), phosphatidylethano-
lamine (PE), plasmalogen-PE (p-PE), 2-acylglycero-3-phosphoe-
thanolamine (lyso-PE), and phosphatidylserine (PS). The four
SLs analyzed were ceramide (CER), dihydro-CER (dhCER), sph-
ingomyelin (SM), and dihydro-SM (dhSM). A tendency for an
increase in the content ofmost of the lipid classes analyzed per cell
(except for lyso-PE, aminor lipid class present in the extracts) was
noticed in WNV-infected cells (Fig. 1C). In fact, statistically sig-
nificant increases in the amounts of PC (1.7-fold), p-PC (1.9-
fold), lyso-PC (1.9-fold), p-PE (1.6-fold), CER (1.8-fold), dhCER
(1.3-fold), and SM (1.4-fold) were noted when infected cells were
compared to uninfected cells. Among the 11 lipid classes analyzed,
a total of 162 different molecular species were identified in HeLa
cells (the complete list of molecular species identified in this and
subsequent analyses is included inData Set S1 in the supplemental
material), with 54 (33.3%) molecular species being significantly
increased upon WNV infection (Fig. 1D). Interestingly, although
a tendency for a reduction of some lipid species was found, at the
level of resolution of this analysis, no statistically significant re-
duction in the content of individual lipid species could be deter-
mined, so we assumed that no major modifications in the level of
the rest of the lipid species occurred in infected cells. The molec-
ular species significantly increased in infected cells included 44
GPLs (13 PCs, 9 p-PCs, 3 lyso-PCs, 5 PEs, and 14 p-PEs) and 10
SLs (5 CERs, 1 dhCERs, and 4 SMs). Therefore, WNV infection
markedly alters the lipid metabolism of host cells.
GPL and SL content of the envelope of flavivirus virions and
RSPs. The lipid composition of viral envelopes can provide novel
clues to understand the biology of these pathogens (7, 9, 10).
Therefore, we studied the GPL and SL content of the viral enve-
lope of WNV. Since the coexpression of flavivirus structural gly-
coproteins (premembrane/membrane [prM/M] and envelope
[E]) results in the assembly and secretion of a sort of virus-like
particle termed a recombinant subviral particle (RSP) that pro-
vides a noninfectious model system to study the assembly and
secretion of flavivirus particles (44, 45), the analysis of the lipid
composition of RSPs was included in this study. A stable HeLa
clone (HeLa3-WNV cells) expressing WNV structural glycopro-
teins (Fig. 2A) that constitutively secrete WNV RSPs of about 30
nm in diameter into the culture medium (Fig. 2B) was used as a
source of RSPs. The identity of these structures was confirmed by
immunogold electronmicroscopy using an antibody against the E
glycoprotein (Fig. 2B inset). In this cell line, immunofluorescence
and confocal analysis revealed that the WNV envelope glycopro-
tein colocalized with markers of the ER (calnexin) and the Golgi
complex (mannosidase II) (Fig. 2C andD). Themolecularweights
of the proteinswere analyzed byWestern blotting using anti-E and
anti-M antibodies (Fig. 2E). As expected, using anti-E antibody, a
single band (about 53 kDa [46]) was observed in samples contain-
ing purified RSPs. In the case of anti-M antibody, two bands, one
band compatible with prMprotein and the other band compatible
with mature M protein (about 20 and 6 kDa, respectively [46]),
were observed. These results confirmed the correct expression of
WNV glycoproteins by cells of the HeLa3-WNV cell line.
Enzyme-linked immunodot assay is faster than Western blot-
ting and allows the analysis of up to 96 samples at once. This kind
of assay has successfully been applied to quantify the amount of
RSPs released into the culture medium by other flaviviruses (47).
Thus, a dot blot assay was used to detect the WNV RSPs released
into the culture medium from HeLa3-WNV cells (Fig. 2F). To
further validate this methodology, the amount of RSPs released
into the culturemedium upon treatment with the Golgi complex-
disturbing agents brefeldin A (BFA) or golgicide A (GCA) was
studied. Treatment of HeLa3-WNV cells with BFA or GCA im-
paired the release of RSPs into the culture medium (Fig. 3A). The
quantification of the blots revealed that BFA or GCA at con-
centrations of 5 M significantly inhibited the release of
RSPs into the culture medium without exerting noticeable
toxic effects on the cells (Fig. 3B). Immunofluorescence analysis
of BFA- or GCA-treated cells confirmed the disruption of the
Golgi complex architecture that these drugs induced (Fig. 3C).
Golgi complex disassembly was concomitant with the accumula-
tion of E glycoprotein inside the cells (Fig. 3C), an observation
consistent with a reduction in the release of RSPs into the culture
mediumobserved in Fig. 3A and B.Overall, these observations are
consistent with previous data showing that flavivirus RSPs, as well
as infectious virions, are assembled by budding into the ER and
then traffic through the secretory pathway (44, 45). Therefore, in
theHeLa3-WNVcellmodel, the lipid envelope of RSPs is acquired
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from the ER in a manner parallel to that observed for infectious
virus (6).
Hence, the lipid composition of the envelope from sucrose
gradient-purified WNV and RSPs was analyzed by mass spec-
trometry and compared to that of total cellular membranes of
HeLa cells (Fig. 4A) following an approach similar to that de-
scribed for other viruses (7–10). The most abundant GPL in viri-
ons, RSPs, and total cellular membranes was PC, although both
RSPs and virions displayed significantly reduced contents of PC
relative to those of the total cellular membranes (about 0.57-fold
for both RSPs and virions). Among the SLs, a significant enrich-
ment in SMwas noticed in the envelope of RSPs and virions com-
pared to the amount in total cellular membranes (about 3.9- and
2.5-fold, respectively). These analyses also revealed that the lipid
composition of both virions and RSPs was very similar for all lipid
classes analyzed, except for p-PC, which appeared to be enriched
in virions compared with the amounts in both RSPs and total
cellular membranes. This could be related to the differences in the
sizes between virions (50 nm) and RSPs (30 nm), since vesicles
formed with p-PC are larger than those formed with PC (48).
Of the 162 lipid species identified in total cellular membranes,
about 95% and 93% were also detected in RSPs (n 	 155) and
virions (n	 152), respectively (see Data Set S1 in the supplemen-
talmaterial). Significant differences in the proportion of lipid spe-
cies between RSPs and virions were restricted to 3 lipid species
(lyso-PC, 18:2; CER, 18:0; dhSM, 24:0; these represented only
about 2% of the total species identified) (see Data Set S1 in the
supplemental material), supporting the suggestion that the lipid
FIG 1 WNV infection alters lipid metabolism. (A) Time course analysis of WNV infection. HeLa cells were infected with WNV (MOI, 50 PFU/cell), and the
amount of infectious virus released into the culture medium was determined by plaque assay at different times p.i. (B) Intracellular membrane rearrangements
in WNV-infected HeLa cells observed by transmission electron microscopy. A micrograph showing the ER from uninfected cells is included for comparison.
Characteristic features of flavivirus-infected cells, vesicle packets (VPs) and virions (Vi), were observed at 24 h p.i. (MOI, 50 PFU/cell). Bars, 200 nm. (C) Relative
amount of different classes of GPLs and SLs in HeLa cells infected or not infected with WNV (MOI, 50 PFU/cell) determined by mass spectrometry at 24 h p.i.
Statistically significant differences are indicated: *, P 0.05; **, P 0.005. (D) Fold differences in individual lipid species significantly increased in infected cells
analyzed as described in the legend to panel C. Dashed line, mean value for each lipid in uninfected cells. Data are presented as the mean SD.
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envelopes of RSPs and virions share multiple common features.
Compared to the lipid species in total cellular membranes, virions
and RSPs displayed significantly altered proportions of 30 (19%)
and 36 (24%) lipid species, respectively, with 15 of them being
significantly altered in both virions and RSPs (Fig. 4B). Among
these common species altered, 5 corresponded to PE or its deriv-
ative, p-PE (4 were enriched [PE, 32:1; p-PE, 32:2; p-PE, 34:3;
p-PE, 36:3] and 1 was reduced [PE, 36:4]), and 6 corresponded to
PC (34:1, 34:3, 36:2, 38:5, 38:6, and 44:3, all of which were re-
duced). Regarding SLs, the enrichment of dhCER (24:0) and three
SM species (16:0, 24:0, and 24:2) was noticed. When lipids en-
riched in both RSPs and virions (Fig. 4B) were compared with
those increased in infected cells (Fig. 1D), only 5 matches were
found (p-PE, 34:3; p-PE, 36:3; dhCER, 24:0; SM, 24:0; SM, 24:1).
Interestingly, three of these species were SLs, suggesting that the
enrichment of these molecular species in infected cells could be
related to an increasing demand for these SLs for the assembly of
the viral envelope.
Involvement of SMandCER in flavivirus biogenesis.The SLs
are derived from sphingosine, a long-chain amino alcohol, which
is acylated with a long-chain fatty acid to give CER, which in turn
is the central core of SM. These lipids are important components
for membrane organization and shape, playing key roles in mul-
tiple cellular processes (49). Our analysis showed that different
FIG 2 WNV RSP as a noninfectious system to study flavivirus biogenesis. (A) Immunofluorescence analysis of the expression of the WNV E glycoprotein in
HeLa3-WNV cells. HeLa or HeLa3-WNV cells were subjected to immunofluorescence analysis using a monoclonal antibody directed against the E glycoprotein
(green) and observed by confocalmicroscopy. Nuclei were stainedwith ToPro3 (blue). Bars, 10m. (B) RSPs produced byHeLa3-WNV cells. The RSPs released
into the culture medium were purified by sucrose gradient centrifugation and observed by negative staining and transmission electron microscopy. (Inset)
Immunogold staining of RSPs using a monoclonal antibody against the E protein. RSPs were detected using protein A coupled to 5-nm colloidal gold. Bars, 100
nm. (C andD)Localization of theWNVEglycoprotein at the ER (C) and theGolgi complex (D) ofHeLa3-WNVcells. Immunofluorescencewas performedusing
a monoclonal antibody directed against the E glycoprotein (green) in combination with rabbit polyclonal antibodies against calnexin (red) to stain the ER or
mannosidase II (red) to stain the Golgi complex. Nuclei were stained with ToPro3 (blue). HeLa cells not expressing viral proteins were included as negative
control. Bars, 10m. (E)Western blot analysis of RSPs purified through a sucrose cushion from the culture medium of HeLa3-WNV cells. Cell culture medium
from control HeLa cells was processed and analyzed in parallel as a negative control. Western blotting was performed using anti-E or anti-M antibodies. (F)
Enzyme-linked immunodot assay using a monoclonal antibody against the E glycoprotein of culture supernatants from HeLa3-WNV cells. Culture medium
from HeLa cells not expressing viral glycoproteins was included as a negative control.
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SLs (CER, dhCER, and SM) were increased in infected cells (Fig.
1C); this was particularly the case for SM, which was found to be
enriched in the lipid envelope of both RSPs and virions (Fig. 4A).
The hydrolytic removal of the phosphocholine moiety of SM by
sphingomyelinases (SMases) to render CER has been associated
with the induction of membrane curvature in SL-enriched mem-
brane domains (50, 51). In fact, compounds that inhibit the activ-
ity of the neutral SMase 2 (nSMase2; also named sphingomyelin
phosphodiesterase 3 [SMPD3]) can inhibit budding processes
(18). Since these observations are compatible with the potential
roles of SLs during WNV infection, i.e., in virion budding and/or
assembly, we first addressed the effect of nSMase inhibition in
HeLa3-WNV cells, used as a model system to study flavivirus bio-
genesis in the absence of virus replication. To this end, we selected
three structurally unrelated nSMase inhibitors (18): GW4869, a
noncompetitive inhibitor of nSMase (34); spiroepoxide, a selec-
tive irreversible inhibitor of nSMase (52); and glutathione, a cel-
lular regulator of nSMase activity (53). Treatment of these cells
with either of these inhibitors significantly reduced the amount of
RSPs released into the culture medium without exerting notice-
able toxic effects on the cells (Fig. 5A to C). GW4869 was the drug
that produced significant inhibition at a lower concentration, so
this compound was selected for further experiments involving
virus infections (see below). As a complementary approach, the
effect of nSMase2 depletion using RNA interference was also an-
alyzed. Silencing of the expression of nSMase2 by transfection
with siRNA, which was verified by Western blotting (Fig. 5D),
significantly inhibited the release of RSPs into the culturemedium
(Fig. 5D and E). When the E-protein content in siRNA-trans-
fected cells was analyzed by Western blotting (Fig. 5D) or immu-
nofluorescence (Fig. 5F), no reductionwas observed in cells trans-
fected with siRNA against nSMase2. These results point to an
accumulation of viral proteins inside cells depleted of nSMase2,
which is consistent with the reduction in the release of RSPs from
cells depleted of nSMase2 that was observed. The extent of the
inhibition of RSP release in cells depleted of nSMase2 by siRNA
(Fig. 5E) was comparable to that exerted by treatment with
nSMase inhibitors (Fig. 5A to C), further supporting the require-
ment for nSMase function during the biogenesis of flaviviruses.
Interferencewith nSMase function reduces flavivirus release
from infected cells. The effect of the nSMase inhibitor GW4869
onWNV infectionwas assayed in twomammalian cell lines (HeLa
FIG3 Treatmentwith BFAorGCA impairs the secretion of RSPs into the culturemedium. (A)RSP release into the culturemediumbyHeLa3-WNVcells treated
(4 h) with the drugs was analyzed by enzyme-linked immunodot assay using amonoclonal antibody against the E glycoprotein. (B)Quantification of the amount
of RSPs released into the culture medium by treated HeLa3-WNV cells from panel A. For each drug concentration, the cellular ATP content is indicated as an
indicator of cell viability upon drug treatment. (C) Localization of theWNV E glycoprotein in infected HeLa cells treated with Golgi complex-disrupting agents.
HeLa3-WNV cells were treated with 10 MBFA or GCA for 4 h. Immunofluorescence was performed using a monoclonal antibody directed against the WNV
E glycoprotein (red) in combination with a rabbit polyclonal antibody against mannosidase II (green) to stain the Golgi complex. Nuclei were stained with
ToPro3 (blue). The panels in the rightmost column display E glycoprotein staining with false coloring from dark purple to bright yellow by use of the fire lookup
table (LUT) scheme to highlight differences in the intensities of the signals. Bars, 10 m.
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and Vero) and one mosquito cell line (C6/36) (Fig. 6A to C).
Treatment with GW4869 at concentrations of 5 M signifi-
cantly inhibited the release of infectious WNV in these three cell
lines, confirming the requirement for nSMase for the production
of WNV in both mammalian and insect cells. The effect of this
inhibitor on infection with Usutu virus (USUV), a related emerg-
ing flavivirus, was also tested in HeLa cells (Fig. 6D). In these
experiments, inhibition of USUV similar to that of WNV at drug
concentrations of 5 M was observed. To analyze whether the
requirement for nSMase function for virus productionwas shared
by other unrelated arboviruses, the effect of GW4869 on infection
with the alphavirus Sindbis virus (SINV) was analyzed (Fig. 6E).
Interestingly, the release of SINV infectious particles from HeLa
cells was not inhibited butwas significantly increased by treatment
with GW4869. This enhancing effect on virus titer was similar to
that previously reported when SINV infection was performed in
cells exhibiting an altered SL content induced by depletion of acid
SMase, which was associated with an increase in virion infectivity
(54). We next addressed the effect of depletion of nSMase2 on
infection with these three viruses by transfection with specific
siRNA (Fig. 6F). Silencing of nSMase2 expression significantly
inhibited the production of both WNV and USUV to an extent
comparable to that produced by treatment with GW4869. Con-
versely, a significant increase in SINV titer was found in cells
treated with siRNA against nSMase2. Therefore, these observa-
tions confirm the results obtained with GW4869 and highlight the
involvement of nSMase function during flavivirus infection.
Inhibition of nSMase activity reduces WNV-induced mem-
brane budding. The mechanism behind the reduction of WNV
growth upon nSMase inhibition using GW4869 was further
studied. The amount of viral particles released into the culture
medium showed a significant reduction, as determined by an
enzyme-linked immunodot assay analyzing the levels of E gly-
coprotein secreted in cells treated with GW4869 (Fig. 7A). This
result was consistent with the decrease in RSP and infectious virus
release observed (Fig. 5A and 6A). Analysis of infected cells treated
with GW4869 by immunofluorescence and confocal microscopy
showed an accumulation of E glycoprotein colocalized with the
ER marker calnexin (Fig. 7B). To rule out the possibility that the
effect of GW4869 on the biogenesis of WNV occurred in a step
after virus assembly or maturation, the amount of cell-associated
infectious virus or infectious virus released into the medium was
determined for cells treated with GW4869 (Fig. 7C). Whereas
treatment with GW4869 significantly reduced the amount of in-
fectiousWNV released, it did not induce an accumulation of cell-
associated infectious virus. When the amounts of cell-associated
viral RNA and viral RNA released into the mediumwere analyzed
(Fig. 7D), a significant reduction of viral RNA levels in the culture
mediumof cells treatedwithGW4869was observed. Conversely, a
significant accumulation of cell-associated viral RNAwas noticed.
Overall, these results are compatible with a reduction in the
amount of infectious virus released with a concomitant accumu-
lation of viral RNA but not the amount of infectious particles
inside GW4869-treated cells, a result which suggests that inhibi-
tion of nSMase function alters a process of flavivirus biogenesis
before the assembly and/or maturation of infectious particles. In-
terestingly, the extent of the inhibition of PFU release (about 60%;
Fig. 7C) was higher than the extent of the inhibition of total par-
ticle or viral RNA release (about 40%; Fig. 7A and D). This could
suggest that GW4869 not only decreases the amount of released
viral particles but also elevates the proportion of secreted nonin-
fectious particles.
As the inhibition of nSMase function can interfere with intracel-
lular budding processes, the effect of GW4869 on virus-mediated
budding was analyzed. To this end, infected cells were treated with
GW4869 and analyzed by transmission electron microscopy (Fig.
7E). Cells treatedwith the nSMase inhibitor displayed ultrastructural
features associatedwithflavivirus infection, i.e., the formationofVPs
FIG 4 Lipid composition of WNV RSPs and virions. (A) GPL and SL compositions of WNV RSPs and virions. The content of individual lipid classes of total
HeLa cells and WNV RSPs or virions was determined by summing the absolute abundances of all species identified. Values are standardized to the mole
percentage of all membrane lipids detected in the sample. Values multiplied by 10 for visibility are indicated. (B) Individual lipid species whose levels were
significantly altered in virions or RSPs in comparison to their levels in total cellular membranes. Data are presented as the mean SD. Statistically significant
differences are indicated: *, P 0.05.
Martín-Acebes et al.
12048 jvi.asm.org Journal of Virology
and thepresenceof electron-densevirions.VPsareproducedbybud-
ding into the ER, and the abundance of these structures can be quan-
tified by transmission electronmicroscopy in flavivirus-infected cells
(55).According to this view, these structureswereanalyzed todirectly
evaluate the effect of nSMase inhibition on viral budding. Themean
diameter of the virus-induced vesicles detected inside theVPs (about
80 nm) in control and GW4869-treated cells was indistinguishable
(Fig. 7F). However, when the number of vesicles inside VPs was
scored, a significant reduction in the number of vesicles inside each
VPinGW4869-treatedcells relative to thenumber incontrol infected
cellswasnoted(meannumbersofvesiclesperVP,1.90.2and5.8
0.6, respectively; Fig. 7G), supporting the suggestion that viral bud-
ding into the ER was reduced upon inhibition of nSMase function.
DISCUSSION
Our results illustrate the alteration of the content of a wide
variety of lipid metabolites inWNV-infected cells. The increase
in the cellular content of PC, lysophospholipids (lyso-PC), SM,
and CER in HeLa cells infected with WNV is consistent with
previous results with mosquito cells infected with DENV (26).
Our analysis also revealed the enrichment of p-PC, p-PE, and
dhCER in WNV-infected cells. Apart from PC, which is a cy-
lindrical lipid, the rest of the lipids whose levels were found to
be increased in WNV-infected cells were conical. The increase
in the levels of these conical lipids could be related to their roles
in the establishment and maintenance of the cellular mem-
brane curvature necessary for proper viral replication complex
assembly, as well as for virion envelopment. The enrichment of
unsaturated PC species in DENV-infected cells has been sug-
gested to be associated with the development of more fluidic
membranes (26). Supporting this idea, all PC species whose
levels were increased in WNV-infected cells were unsaturated.
Likewise, the observed enrichment of SLs (CER, dhCER, and
SM) inWNV-infected cells is also compatible with the require-
FIG 5 Impairment of nSMase function inhibits the release of RSPs. (A to C) Treatment with the nSMase inhibitor GW4869 (A), spiroepoxide (B), or
glutathione (C) impairs the release of RSPs by HeLa3-WNV cells. The content of RSPs in the culture medium of cells treated (for 4 h) with the drugs was
determined by enzyme-linked immunodot assay using a monoclonal antibody against the E glycoprotein. The amount of RSPs determined by enzyme-
linked immunodot assay was quantified, and the cellular ATP content for each drug concentration is shown in the graphs. (D) Depletion of nSMase2 by
RNA interference. HeLa3-WNV cells were transfected with universal negative-control siRNA or with siRNA against nSMase2 for 48 h, and the amount of
nSMase2, E glycoprotein, and -actin in cell lysates was analyzed by Western blotting using specific antibodies. RSP release into the culture medium after
4 h of incubation in cells transfected for 48 h with siRNA was analyzed by enzyme-linked immunodot assay using an anti-E antibody. (E) Quantification
of the amount of RSPs released into the culture medium by HeLa3-WNV cells transfected with siRNA control or against nSMase2 from panel D. The
cellular ATP content for each drug concentration is shown as an indicator of cell viability upon drug treatment. (F) Immunofluorescence analysis of the
expression of the WNV E glycoprotein in HeLa3-WNV cells transfected with siRNAs. HeLa or HeLa3-WNV cells transfected as described in the legend to
panel D were subjected to immunofluorescence analysis using an antibody directed against E glycoprotein (green) and observed by confocal microscopy.
Nuclei were stained with ToPro3 (blue). The panels on the right display E glycoprotein staining with false coloring from dark purple to bright yellow by
use of the fire lookup table (LUT) to highlight differences in the intensity of the signal. Bars, 10 m. Data are presented as the mean  SD. Statistically
significant differences are indicated: *, P  0.05; **, P  0.005.
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ment for these molecules in the membranes where virus repli-
cation and assembly take place. According to this hypothesis, it
has been documented that DENV and hepatitis C virus repli-
cation complexes are enriched in SLs (17, 26).
To identify the potential roles of the lipid classes analyzed in
the biogenesis of WNV particles, the proportion of each lipid in
both purified virions and RSPs was analyzed. All lipid classes an-
alyzed, including PS, which has been shown to play a functional
role during flavivirus entry, were detected in the envelopes of
WNV and RSPs (11). The high degree of similarity between the
lipid composition of RSPs and virions, along with their parallel
mechanisms of formation, reinforces the view that RSPs are a
valuable tool for the study of lipid involvement during the biogen-
esis of flaviviruses.
We next addressed the question of whether the lipid composi-
tion of the WNV envelope was similar to that of total host cell
membranes or if it reflected that of a particular membrane do-
main, following an approach similar to the approaches used for
the characterization of other viral envelopes (7, 10). This analysis
indicated that the envelopes of both RSPs and virions were en-
riched in SM and exhibited a reduction in the content of PC com-
pared to that of total cellularmembranes. Similar features, such as
an increase in the SM (or other SL) content and a depletion of PC,
have also been observed in the lipid envelopes of human immu-
nodeficiency virus type 1 (HIV-1) and influenza virus (7, 9). On
the contrary, the rhabdovirus vesicular stomatitis virus and the
alphavirus Semliki Forest virus exert little lipid selection when
they acquire their envelopes (8). The characteristics of the WNV
envelope also differed from those of the hepatitis C virus envelope,
which more closely resembles the composition of very low- and
low-density lipoproteins (10). Enrichment in SLs and a reduction
of PC levels are characteristics of liquid ordered membrane mi-
crodomains or membrane rafts (7, 9, 18, 56). Since membrane
raft-like microdomains, including those located in the ER (57),
are usually cholesterol enriched (7, 9, 18, 56), our findings could
be connected to the role(s) of membrane microdomains enriched
in cholesterol in flavivirus infections (28, 31, 58–60). SL-enriched
membrane microdomains have functional properties directly
linked to their lipid composition, such as coalescence and the
promotion of budding processes during virus assembly (7, 9) or
exosome biogenesis (18). Indeed, flavivirus assembly by invagina-
tion of ER membrane shares topological features with the forma-
tion of exosomes, since both processes mainly consist of budding
outward from the cell cytoplasm. Supporting this hypothesis, the
parallelism between viral budding processes and exosome biogen-
esis has already been documented (61, 62). An important point
that must also be considered in these analyses is that in the RSP
system, HeLa3-WNV cells express viral prM and E proteins in the
absence of any other viral protein. Since viral nonstructural pro-
teins (such as NS4A) induce membrane proliferation (63, 64),
FIG 6 Impairment of nSMase function inhibits the release of WNV. (A to C) Treatment with the nSMase inhibitor GW4869 reduces WNV production in
mammalian and insect cells. HeLa (A), Vero (B), or C6/36 (C) cells were infected with WNV (MOI, 1 PFU/cell) and treated with the indicated drug, and the
amount of infectious virus released into the culturemediumwas determined by plaque assay at 24 h p.i. The cellular ATP content of uninfected cells treated with
the different concentrations of the drug is indicated in all graphs as an estimate of cell viability upon drug treatment. (D) Treatment withGW4869 reducesUSUV
production. HeLa cells were infected with USUV (MOI, 1 PFU/cell), and the amount of infectious virus released was determined as described in the legends to
panels A toC. (E) TreatmentwithGW4869 increases SINVproduction.HeLa cells were infectedwith SINV (MOI, 1 PFU/cell), and the amount of infectious virus
released into the culturemediumwas determined by plaque assay (8 h p.i.). (F) Effect of nSMase2 depletion by siRNAonWNV,USUV, and SINV infection.HeLa
cells were transfected with a universal negative siRNA control or with siRNA against nSMase2 for 48 h and infected withWNV, USUV, or SINV, and the amount
of virus released into the culture medium was analyzed as described in the legend to panels A to C. Data are presented as the mean SD. Statistically significant
differences are indicated: *, P 0.05; **, P 0.005.
Martín-Acebes et al.
12050 jvi.asm.org Journal of Virology
their expression is expected to modify cellular lipids in infected
cells. In fact, modification of cellular lipids upon infection with
WNV was confirmed by analysis of the lipids in WNV-infected
cells. Therefore, it is foreseeable that the lipid components from
WNV-infected cells can differ from those of RSP-producing cells,
which may explain some of the minor differences between RSPs
and virions found in the analysis, such as the amount of p-PC or
variations in the specific lipid species found between RSPs and
FIG 7 Inhibition of nSMase function reduces WNV-induced budding. (A) Treatment with the nSMase inhibitor GW4869 reduces WNV release. HeLa cells were
infectedwithWNV(MOI, 1PFU/cell) and treatedwith the drug, and the amount of virus particles released into the culturemediumwas estimatedby an enzyme-linked
immunodotassayusingamonoclonal antibodyagainst theEglycoproteinat24hp.i. (B)Localizationof theWNVEglycoprotein inHeLacells infectedwithWNV(MOI,
1 PFU/cell) and treated with 10 M GW4869. Immunofluorescence was performed using a monoclonal antibody directed against the E glycoprotein (green) in
combination with a rabbit polyclonal antibody against calnexin (red) to stain the ER at 24 h p.i. Nuclei were stained with ToPro3 (blue). The panels in the rightmost
columndisplay E glycoprotein stainingwith false coloring fromdark purple to bright yellow by use of the fire lookup table (LUT) scheme to highlight differences in the
intensities of the signals. Bars, 10m. (C) Impairment of nSMase functionwithGW4869does not increase the amount of cell-associatedWNV.HeLa cellswere infected
withWNV(MOI, 1PFU/cell), and the amountof virus either releasedor cell associatedwasdeterminedbyplaqueassay at 24hp.i. (D)Theamountof viralRNAreleased
into the culturemediumor cell associatedwas determined by quantitative RT-PCR in cells infected and treated as described in the legend to panel C. (E) Representative
electron micrographs at 24 h p.i. of cells infected withWNV (MOI, 10 PFU/cell) and treated or not treated (control) with 10 MGW4869 showing the formation of
vesicle packets (VPs) containing virus-induced vesicles (Ve) and electron-dense virions (Vi). Bar, 200 nm. (F)Diameter of virus-induced vesicles detected in the VPs of
cells infectedand treatedornot treatedwith10MGW4869.Eachpoint represents an individual virus-inducedvesicle. Solid linesdenote themeanvesiclediameter. (G)
Number of virus-induced vesicles per VP detected in the VPs of cells treated or not treated with 10MGW4869. Each point represents the number of virus-induced
vesicles detected in an individualVP. Solid lines denote themeannumber of virus-induced vesicles perVP.Unless specified otherwise, data are presented as themean
SD. Statistically significant differences are indicated: **, P 0.005.
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virions. However, the major features observed (a reduction of PC
and enrichment in SM) were common between the two systems,
supporting the use of RSPs as a model to study flavivirus bio-
genesis.
The hydrolysis of SM by nSMases converts SM into CER, a
compound with a smaller head size (49). CER induces an asym-
metric membrane tension and segregates into highly ordered do-
mains triggering modifications of membrane shape (65). These
properties have been associated with the promotion ofmembrane
bending and budding processes both on model membranes (50)
and in living cells (18, 51, 66, 67). In this scenario, pharmacolog-
ical inhibition of nSMase activity, which catalyzes the hydrolysis
of SM to CER, impaired the release of RSPs into the culture me-
dium and reduced the level of production of infectious particles of
WNV and the related flavivirus USUV, which parallel the effects
on the production of certain types of exosomes that have been
documented (18, 66, 67). Supporting this observation, depletion
of nSMase2 by RNA interference inhibited the release of RSPs and
the production of WNV and USUV. On the contrary, an increase
in the titer of another arbovirus (SINV) was observed upon inhi-
bition of nSMase function, therefore indicating that the require-
ment for the conversion of SM to CER during the biogenesis of
flavivirus is not shared by this alphavirus. Consistent with these
results, lipid recruitment during alphavirus envelopment has been
proposed to be a process with a low level of selection (8), in con-
trast to the enrichment of SM and the reduction in the level of PC
described here for the flavivirus envelope. Alphavirus biogenesis is
dependent on the functionality of the secretory pathway, since
viral envelope glycoproteins must traffic from the ER through the
Golgi complex to the plasma membrane for viral budding (68).
Thus, the lack of inhibition of SINV release upon pharmacological
inhibition of nSMase2 or siRNA-mediated depletion of this en-
zyme shows the functionality of the secretory pathway in cells
treated with GW4869 or siRNA against nSMAse2. This observa-
tion further supports the specific involvement of nSMase2 in the
biogenesis of flavivirus. Although other nSMases are expected to
be functional in cells depleted of nSMase2 by siRNA, the degree of
inhibition (of RSPs and virion release) achieved with specific
siRNA against nSMase2 was similar to that observed using the
nSMase inhibitor GW4869, thus reinforcing the idea that
nSMase2 is the main nSMase involved in flavivirus biogenesis.
When the effect of nSMase inhibition on virus biogenesis was
analyzed by several approaches, a reduction of the amount of vi-
rus-induced vesicles inside VPs in cells treatedwith an inhibitor of
nSMase function was noticed. Since these vesicles are associated
with flavivirus replication and virion envelopment (5, 43, 55), this
observation supports the role of SM conversion to CER in virus-
induced budding. The diameter of the vesicles found in cells
treatedwith the nSMase inhibitorwas similar to that of the vesicles
observed in untreated cells. A possible explanation for this phe-
nomenon could be that vesicle components others than lipids
(presumably, viral proteins) also contribute to vesicle formation,
although the inhibition of nSMase activity makes this assembly
less efficient. Accordingly, an important role for viral glycopro-
teins in the induction andmaintenance ofmembrane curvature in
flavivirus virions has been proposed (69). Since budding mecha-
nisms are usually driven by a regulated combination of proteins
and lipids (70), our results indicate that, indeed, the lipid compo-
sition of the flavivirus envelope also contributes to this process.
Interestingly, the dhCER content was found to be increased in
WNV-infected cells, as it was one of the molecular species en-
riched in the viral envelope (dhCER, 24:0). This metabolite is an
intermediate in the SL biosynthetic pathway (49), and the pres-
ence of increased levels of dhCERpoints to the upregulation of the
de novo synthesis of SLs withinWNV-infected cells, as reported in
other virus models (17, 26). On the other hand, the involvement
of nSMase in WNV and USUV biogenesis indicates that the pro-
duction of CER by the hydrolysis of SM is also required during
infection with these pathogens, providing evidence of the
functionality of these two pathways for CER production in flavi-
virus-infected cells. However, one must be cautious with the in-
terpretation of the reason for the increase in CER levels in WNV-
infected cells, since this can be due to different factors, such as the
induction of ER stress (71) mediated by the activation of the un-
folded protein response in flavivirus-infected cells (72).
In summary, our results provide additional evidence of the
complex degree of manipulation of host cell lipid metabolism by
WNV. These results also unveil a connection between SL metab-
olism and flavivirus biogenesis. The findings presented here could
contribute to the further development of lipid-based antiviral
strategies to combat these pathogens.
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